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A COMPARISON OF 
FAILURE MODES OF 
GLUTARALDEHYDE-TREATED 
VERSUS ANTIBIOTIC- 
PRESERVED MITRAL VALVE 
ALLOGRAFTS IMPLANTED 
IN SHEEP 
Morphologic studies and calcium analyses were made on mitral valvq 
ailografts from 12 juvenile sheep surviving 12 to 24 weeks after mitral valw 
replacement. Before implantation, the allografts were treated with 0.625~, 
glutaraldehyde (group I, n = 4) or with cold antibiotic solution (group I I  
n = 8). Three group I animals died 12 to 19 weeks after implantatio~ 
because of dysfunction of calcified valves; the surviving animal also hac 
extensive allograft calcification. One group II animal died of mitra 
regurgitation; the valves of the other seven (including five with regurgita 
tion shown by Doppler and ventriculographic studies) were explanted at 1! 
to 24 weeks. Chordal rupture related to calcific deposits was found in al 
group I valves. Leaflet perforations (n = 4) and ruptured chordae (n = 4) 
each caused by connective tissue deterioration, were found in group I3 
valves. Inflammatory eaction was absent or minimal in group I valves bu 
moderate or severe in group I I  valves. Fibrous sheaths were thicker il 
group I I  than in group I valves. Calcium levels were much higher in groul 
I than in group II valves. Calcification in group I valves was diffuse am 
involved collagen, elastic fibers, and connective tissue cells and matrix; it 
group II valves, it was localized in connective tissue ceils. Thus glutaral 
dehyde-treated ailografts failed because of extensive calcification, wherea~, 
antibiotic-preserved allografts underwent deterioration ofconnective tissm 
and infiltration by inflammatory cellS. (J TrIORAC CARDIOVASC SURG 1995 
110:224-38) 
Koichi Tamura, MD, PhD, a Michael Jones, MD, b 
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Two major types of tissue valves have been devel- 
l oped  for use as replacement heart valves: valvu- 
lar heterografts (bioprostheses) and allografts (ho- 
mografts).l, 2 Because of reasons related to ease of 
procurement, standardization of methods of preim- 
plantation processing, and availability from com- 
mercial sources, valvular heterografts have been 
used much more extensively than allografts. Al- 
though several different methods of preimplantation 
processing have been used for human heart valve 
allografts, 3-5 at the present time the majority of 
these valves are processed with solutions containing 
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antibiotics and antifungal agents, often followed b~ 
cryopreservation. Most experimental and clinica 
studies of allografts have used either aortic 01 
pulmonary valves, and these have been used to1 
aortic and mitral valve replacement, 6-9 as well as to1 
reconstruction of the right ventricular outflo~ 
tract 1~ and for "the pulmonary switch, ''13 wit[ 
excellent long-term results. Although early report~ 
documented the successful implantation of mitra 
and tricuspid valve allografts in human patients, 14,1~ 
long-term follow-up revealed late deterioration o: 
allograft function in every case. 16 Other investiga. 
tors subsequently reported implantation of mitra 
allografts in the mitra117 and tricuspid TM positions ir 
patients. A recent study, based on the experienc~ 
gained with porcine aortic valvular heterografts 
which are processed by exposure to low concentra. 
tions of glutaraldehyde, has used porcine mitra 
valves treated with this agent before implantation ir 
human patients. 19 Nevertheless, no data have beer 
reported on the use of allografts or heterograft~ 
constructed of mitral valvular tissue and implantec 
in the atrioventricular position in experimental ni. 
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mal models. A considerable amount of information 
has been gathered on the results of  implantation of 
variously processed porcine aortic and pericardial 
bioprostheses in the juvenile sheep model, z~ 21 Re- 
cently, replacement of a portion of  the mitral valve 
by an antibiotic-treated and cryopreserved mitral 
allograft issue has been reported in sheep. 22 In view 
of these reports, it was considered of interest o use 
the sheep model to evaluate the results obtained by 
replacing the mitral valve with fresh, antibiotic- 
preserved or glutaraldehyde-treated mitral allografts. 
Materials and methods 
Animals used. Donor altografts were obtained from a 
mixed breed (Rambouillet, Dorset, Hampshire, and Suf- 
folk) of male and female juvenile domestic sheep. Sheep 
of the same breed and from the same commercial source 
(Ovine Biotechnologies, Inc., New Hope, Pa.) served as 
recipients. The sheep were 25 to 35 weeks old and 
weighed 20 to 35 kg. All animals received care as pre- 
scribed by the Guide for the Care and Use of Laboratory 
Animals (NIH Publication No. 80-23, revised 1985). Pro- 
cedures for preoperative, intraoperative, and postopera- 
tive management were approved by the Animal Care and 
Use Committee of the National Heart, Lung, and Blood 
Institute. 
Preparation of the allografts. Anesthesia was induced 
with diazepam (0.4 mg/kg) and sodium pentobarbital (5 
mg/kg) and maintained with either 0.5% to 1.0% halo- 
thane or 1% to 2% isoflurane in oxygen. After adminis- 
tration of beef lung sodium heparin sulfate (300 units/kg), 
the animals were killed with potassium chloride (30 mEq) 
given intravenously. Valves were procured under clean 
but not surgically sterile conditions. The mitral valve was 
excised with a 2 to 3 mm rim of left atrial muscle above the 
anulus and 2 to 3 mm of the tips of the papillary muscles. 
Only valves with single discrete anteromedial nd postero- 
lateral papillary muscle heads were considered suitable 
for implantation. If the valvular anulus accommodated 
standard commercial valve sizers of 25 or 27 mm, they 
were considered to be of appropriate sizes for implanta- 
tion. After being harvested, the valves were placed in 
either phosphate-buffered 0.625% glutaraldehyd e (pH 
7.4) or buffer and antibiotic solution containing cefoxitin 
240 t~g/ml, lincomycin 120 /xg/ml, polymyxin 100 /xg/ml, 
and vancomycin 50 /xg/ml in 0.9% saline. They were 
maintained at 4 ~ C until implantation (1 to 7 days for the 
antibiotic-treated valves and 2 to 16 weeks for those fixed 
w i th  glutaraldehyde). Before implantation, the valves 
were passed through three washes of 0.9% saline contain- 
ing beef lung sodium heparin 5000 units/500 ml. 
Surgical implantation. The recipients for the allograft 
valves were fasted overnight before the operation. Anes- 
thesia was induced and maintained as described earlier. 
Mechanical ventilation was instituted via a 9 mm cuffed 
endotracheal tube with a volume-cycled mechanical ven- 
tilator at a rate of 12 to 14 cycles per minute, a tidal 
volume of 10 to 15 ml/kg, and 100% oxygen. The mechan- 
ics of ventilation were adjusted according to frequently 
determined arterial blood gas analyses. Electrocardio- 
graphic signals were recorded from four limb leads. 
Procaine penicillin, 900,000 IU administered intramuscu- 
larly, and gentamicin, 75 mg administered intravenously, 
were given as prophylactic antibiotics. Succinylcholine 
chloride was given to provide muscle relaxation before 
thoracotomy and was not repeated. 
Systemic blood pressure was monitored via a right 
femoral artery catheter. A Swan-Ganz catheter (Baxter 
Healthcare Corp., Edwards Division, Santa Ana, Calif.) 
was passed into the pulmonary arteryvia the right femoral 
vein, and the pulmonary artery pressure was similarly 
monitored and recorded. Cardiac output was determined 
by computer analysis of the thermodilution curves. 
Under surgically sterile conditions, a thoracotomy inci- 
sion, sparing the pectoralis major muscle, was made in the 
left fourth intercostal space. The left internal thoracic 
vessels were ligated, the left lung was retracted caudally 
and dorsally, and the pericardium was opened and re- 
tracted. 
The circuit for cardiopulmonary b pass consisted of a 
Cobe roller pump system (model 043600-000, Cobe Lab- 
oratories, Inc., Lakewood, Colo.) attached to a Mediflex 
3/8 • 2/32-inch extracorporeal tube (Gish Biomedical, Inc., 
Santa Ana, Calif.) and a Bentley BCR 2500 cardiotomy 
reservoir with an attached bubble oxygenator (Bentley 
Laboratories Division, Irvine, Calif.). The prime was 
prepared by delivering 500 ml of 0.9% sodium chloride 
and 2 units of autologous blood into the reservoir, to 
which 54.4 mg of calcium chloride and 6000 units of beef 
lung sodium heparin sulfate were then added. The bypass 
circuit Was activated, air was evacuated by means of a 
three-way stopcock attached to the filter, and oxygen was 
delivered to the oxygenator through an arterial filter at a 
rate of 1 L/min. The prime was warmed and maintained 
between 37 ~ and 39 ~ C. 
The left femoral artery was cannulated for arterial 
perfusion, and the right ventricle was cannulated through 
the main pulmonary artery for the venous return. Normo- 
thermic cardiopulmonary b pass was instituted at a flow 
rate of 100 ml/min per kilogram and adjusted to maintain 
a mean blood pressure of 70 to 80 mm Hg. The aorta was 
not clamped; hypothermia was not attempted, and the 
heart was neither arrested nor fibrillated. The left ventri- 
Cle was vented through an apical stab incision by means of 
an 18F catheter. The distal pulmonary artery was oc- 
cluded with an umbilical tape and attached snare. 
A left atriotomy was made between the left atrial 
appendage and the entrance of the left hemiazygous vein 
into the coronary sinus. The papillary muscles were 
transected at their bases and the mitral valve was excised, 
with a 2 to 3 mm remnant of valvular tissue left at the 
anulus. Nonabsorbable interrupted mattress utures of 3-0 
Tevdek polyester (Deknatel Div., Pfizer, Inc., Fall River, 
Mass.) buttressed with Teflon felt pledgets were passed 
through the atrial aspect of the mitral anulus. The sutures 
were passed through the anulus of the allograft valve so 
that the orientation of the valve being implanted was 
identical to that of the valve that had been excised. Any 
redundancy of allograft annular tissue was plicated at the 
commissures. The papillary muscles were reimplanted at 
the sites of the recipient's papillary muscle bases with a 
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single Teflon felt-reinforced horizontal mattress suture of 
0 Tevdek polyester placed transmurally for each papillary 
muscle. The atriotomy was repaired with 6-0 Prolene 
suture (Ethicon, Inc., Somerville, N.J.) and the pulmonary 
artery snare was released. Air was evacuated from the left 
atrium and the left ventricle, and the animal was sepa- 
rated from cardiopulmonary b pass. Intravenous infusions 
of isoproterenol r nitroglycerin, or both, were used as 
necessary. A single chest tube was placed in the anterior 
mediastinum through a stab incision made at the sixth 
intercostal space. The femoral artery was repaired with 
6-0 Prolene suture, and the groin and chest were closed in 
layers. 
After operation, the animals were maintained in inten- 
sive care oxygen compartments with oxygen concentra- 
tions set at 40% for the first 24 to 36 hours. Furosemide, 
150 mg twice daily, and digoxin, 0.25 mg once daily, were 
given for 10 to 14 days. After recovery, the animals were 
returned to the National Institutes of Health Animal 
Center, Poolesville, Maryland, and maintained by conven- 
tional ovine husbandry techniques. 
Hemodynamic studies at the time of explantation. 
Anesthesia was induced and maintained as before. A 
Swan-Ganz catheter was positioned in the main pulmo- 
nary artery via the femoral vein. A catheter was positioned 
in the right common femoral artery for monitoring sys- 
temic arterial pressure and arterial blood gases. These 
catheters were interfaced with a physiologic recorder with 
the use of fluid-filled pressure transducers. Arterial blood 
gases and pH were maintained within physiologic ranges. 
The thorax was opened through a bilateral transverse 
thoracotomy in the fifth intercostal space and extended 
across the sternum. Left atrial and left ventricular pres- 
sures were obtained from intracavitary catheter-tipped 
transducers positioned transmurally. Four consecutive 
cardiac cycles were analyzed for each hemodynamic de- 
termination. A hydrostatic standard was used for calibra- 
tion of all pressure recordings. Left ventricular and left 
atrial pressures were superimposed and recorded simul- 
taneously. The areas between the left ventricular and left 
atrial pressure curves during the diastolic filling periods 
were measured by planimetry. The mean diastolic pres- 
sure differences were obtained as the averages of four 
beats. Effective mitral orifice areas (MOA) were calcu- 
lated with the use of a modified Godin and Gorlin 
equation: MOA = CO/(37.9 • DFT • ~/APmean • HR) 
where CO = cardiac output, DFT = diastolic filling time, 
AP . . . . .  = mean transvalvular p essure difference, and HR 
= heart rate. The thermodilution method with determi- 
nations of an average of five injections of 5 ml of ice-cold 
(0 ~ to 4 ~ C) saline solution was used for measuring cardiac 
output and, in the absence of significant mitral regurgita- 
tion, it was assumed to be identical to the transmitral flow 
rate per minute. 
A 7F pigtail catheter was positioned in the left ventric- 
ular apex, and left ventriculography was performed to 
assess mitral regurgitation. Ultrasound studies (imaging, 
standard spectral Doppler echocardiography, and two- 
dimensional, color-encoded Doppler echocardiography) 
were also made to evaluate mitral regurgitation. The 
animal was killed with intracardiac potassium chloride. 
Morphologic evaluation of valves. All major organs 
were weighed and examined grossly and microscopically 
for evidence of infarction and hemosiderin deposition 
(hematoxylin-eosin a d Pert's stain for iron): For evalua- 
tion of valve-induced hemolysis, determinations were 
made of hematocrit, red blood cell count, hemoglobin, 
reticulocyte count, serum free hemoglobin, serum lactate 
dehydrogenase, and bilirubin. 
After removal of the heart, the valve was examined 
grossly in situ for evidence of dysfunction. It was further 
evaluated for the presence of vegetations, thrombotic 
material, signs of structural degradation, tears or perfora- 
tions, fibrous tissue ingrowth, perivalvular leaks, and 
calcific deposits. Any vegetations were cultured. In situ 
photographs of the inflow and outflow surfaces of the 
valve were taken. The prosthesis was removed from the 
heart and fixed in McDowell's solution.? 3 After fixation, 
gross photographs of the inflow, outflow, and lateral 
aspects of the valve were taken with the valve immersed in 
saline solution. Macrophotographs were taken at magni- 
fications from 2• to 8• with a dissecting photomicro- 
scope. A roentgenogram of the valve was taken with soft 
tissue techniques. For quantitative evaluation of mineral- 
ization, one half of each of the anterior and posterior 
leaflets was submitted for analyses of calcium and phos- 
phorus content by atomic absorption spectrophotometry. 
Before the calcium and phosphorus analyses, the halves ot 
the leaflets were subdivided into leaflet proper, chordae 
tendineae; and papillary muscle portions. The other halt 
of each leaflet was processed for light and electron 
microscopy. 1 The following groups of valves (each, n = 2) 
were used as controls: (1) fresh, unprocessed mitral valves 
that were excised immediately after the animal was killed 
and were placed directly in McDowell's solution23; (2) 
unimplanted glutaraldehyde-treated valves, and (3) unim- 
planted antibiotic-preserved alves. 
Results 
Glutara ldehyde- t reated valves were implanted in 
seven sheep. Two of them died of  pulmonary edema 
and mitral  regurgitat ion and calcif ication within 12 
weeks after operat ion;  another died of bacterial 
endocardit is  at 18 weeks. These three animals were 
excluded from the study. Of the remain ing  fore 
animals, three died of valvular dysfunction and 
card iopulmonary fai lure between 12 and 19 weeks. 
and another  was put  to death at 19 weeks. The lattm 
animal showed severe mitral  stenosis with a mea~ 
left atrial pressure of 12 mm Hg, mean transmitral 
valvular gradient of 6 mm Hg, a forward cardiac 
output of 1.68 L/rain, and a calculated valve area oJ 
only 0.5 cm 2. Doppler  and eineventrieulography con- 
f irmed the presence of severe mitral regurgitatior 
caused by fracture of calcified chordae tendineae. 
Ant ib iot ic -preserved valves were implanted in 1L 
sheep. Six of them died in less than 12 weeks afteJ 
operat ion and were excluded from the study. Three 
of these animals had bacter ial  endocardit is,  and the 
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other three had severe pulmonary edema, mitral 
regurgitation, and rupture of the chordae tendineae. 
The remaining eight sheep survived 12 to 24 weeks. 
One sheep died of mitral regurgitation at12 weeks. 
The other seven were put to death after hemody- 
namic study. Five of the seven animals showed 
moderate to severe mitral regurgitation by Dopp- 
ler echocardiographic and/or cineventriculographic 
study. For all seven animals, hemodynamic f ndings 
(expressed as mean __ standard error of the mean) 
were as follows: mean left atrial pressure, 19.5 _+ 1.2 
mm Hg; mean diastolic pressure gradient, 8.5 - 1.1 
mm Hg; Gorlin and Gorlin calculated mitral valve 
area, 1.1 _+ 0.1 cm 2, With forward cardiac output of 
2.18 _+ 0.21 L/min. Increased pressure gradients and 
decreased calculated valve areas were thought to be 
influenced by the increased transmitral flow because 
of the regurgitation. 
Cardiac gross anatomic findings 
Explanted group I (glutaraldehyde-treated) valves. On 
gross anatomic inspection, three valves appeared 
stenotic and one regurgitant. Fibrous sheaths ex- 
tended for variable distances from the valve ring 
toward the free edges of the leaflets and from the 
papillary muscles onto the chordae tendineae. All 
valves contained calcium deposits, which formed 
either flat, yellowish plaques or raised nodules. The 
chordae tendineae had lost their elasticity and con- 
tained extensive yellowish deposits of calcium (Fig. 
1, A). Several calcific nodules were also present on 
these chordae (Fig. 1, B). Some of the secondary 
chordae were ruptured in each of the four valves. 
Explanted group II (antibiotic-preserved) valves. Five 
of the valves were regurgitant and none were stenotic. 
The leaflets were covered by fibrous sheaths (Fig. 1, 
C). In general; the fibrous sheaths in the leaflets and 
the chordae (Fig. 1, F) were thicker in these valves 
than in group I valves. The areas of the leaflet hat 
were not covered by fibrous sheaths were traiaslucent 
and thinner than normal (Fig. 1, D). Perforations of 
the leaflets were found in four valves (Fig. 1, E). All of 
these perforations differed morphologically from those 
that we have observed in tissue valves as a result of 
bacterial infection 24 or abrasion by excessively tong 
ends of sutures. 25 Other chordae were thinner than 
normal, and rupture of the primary chordae was found 
in four valves (three of which also had perforations of
the leaflets). The tips of these ruptured chordae were 
tapered and noncalcified (Fig. 1, G). 
Radiographic findings 
Explanted group I valves. The extent of calcification 
was much greater in group I than in group II valves. 
The great majority of the chordae tendineae showed 
diffuse calcification. The leaflets also had diffuse calci- 
fication, especially at the valve anulus. The calcific 
deposits extended from this area to the points of 
insertion of the chordae into the leaflets (Fig. 2, A). 
Explanted group H valves. Very small, focal areas 
of calcifcation were found in some chordae at their 
points of attachment to the papillary muscles and on 
the Teflon pledgets at the valve rings and papillary 
muscles (Figl 2, B). 
Quantitative measurements of calcium contents. 
The calcium content of explanted valves was much 
higher in group I than in group II animals. In fact, 
the values in group II valves were only slightly 
higher than those in normal (untreated) control 
valves. Calcium analyses howed values (milligrams 
of calcium per gram dry tissue weight _+ standard 
error of the mean) of 249 _+ 83, 88 _+ 56 and 100 _+ 
32 in the anterior leaflet, posterior leaflet, and chor- 
dae, respectively, in group I allografts, and, 1.4 _+ 0.3, 
3.0 _ 1.1, and 11.7 _+ 6.4 in the anterior leaflet, 
posterior leaflet and chordae, respectively, ingroup II 
allografts. Corresponding values for control valves 
were 0.38 _+ 0.05, 0.38 +_ 0.07, and 0.26 +_ 0.03. 
Histologic observations 
Unimplanted, untreated valves. In each leaflet, 
four distinct issue layers were evident (Fig. 3, A) 
from the atrial to the ventricular aspects: theatrialis, 
the spongiosa, the fibrosa, and the ventricularis. The 
leaflet surfaces were covered by endothelial cells. 
The atrialis contained layered elastic fibers and a 
few collagen fibers. Fibroblasts and myofibroblasts 
were present in all four layers of the leaflet and the 
chordae tendineae. The spongiosa contained elastic 
fibers, collagen fibers, and abundant proteoglycan 
material. Cardiac myocytes, adipose tissue cells, and 
capillaries were found in the spongiosa in the basal 
third of the leaflet. The fibrosa consisted of thick 
bundles of collagen fibers. The ventricularis con- 
tained small amounts of elastic fibers and collagen 
fibers. This layer usually extended only along the 
proximal two thirds of the leaflet; in the distal third, 
the fibrosa wag directly subjacent to the endothelial 
lining: The connective tissue at the free edge of the 
leaflet was loosely arranged, with a few bundles Of 
collagen and abundant proteoglycan materials. 
The chordae tendineae were composed of two 
regions: an outer layer and an inner fibrous core 
(Fig. 3, B). The outer layer, which sometimes was 
very thin, consisted Of endothelial cells and a sub- 
endothelial layer containing a few sparse collagen 
fibers and elastic fibers. The outer layer also con- 
228 Tamura et aL 
The Journal of Thoracic an, 
Cardiovascular Surger 
July 199 
Fig. 1. Gross photographs of group I (A and B) and group II (C to G) allografts implanted inthe mitral position 
in sheep for 12 to 20 weeks. A, The valve leaflet and chordae tendineae contain extensive calcium deposits and 
some of the chordae are ruptured. B, Large calcific deposit is evident on a chorda tendinea. C, The leaflet and 
chordae are covered by thick fibrous sheath. D, Theareas of the leaflet hat are not covered by fibrous sheath 
are translucent and thinner than normal. E, Inflow surface of valve showing perforation of the leaflet. F, Many 
chordae tendineae are thickened by fibrous sheaths. G, The tip of a ruptured chorcla is tapered and noncalcified. 
tained proteoglycan materials, particularly at the 
points of branching o f  the chordae. The inner 
fibrous cores consisted of thick, longitudinally ar- 
ranged collagen bundles. 
Unimplanted group I valves. The structure of the 
unimplanted group I valves was normal. Tissues from 
glutaraldehyde-treated valves tended to be more eosi- 
nophilic than those of the untreated valves. 
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Fig. 2: Roentgenograms of group I (A) and group II (B) allografts. A, Extensive calcific deposits are 
evident in the leafet and chordae tendineae. B, Very small, focal areas of calcification are found in some 
chordae tendineae. 
Fig. 3. Histologic features of unimplanted, untreated mitral valves. A, The following tissue layers are 
present in the anterior leaflet: the auricularis (A), the spongiosa (S), the fibrosa (F), and the ventricularis 
(V). (Hematoxylin-eosin tain, • 150.). B, A chorda tendinea has two distinct connective tissue regions: an 
outer, loosely arranged layer and an inner fibrous core. (Hematoxylin-eosin stain, • 100.) 
Unimplanted group H valves. The changes ob- 
served in the unimplanted group II valves included 
focal loss of endothelial cells and edema of the 
sp0ngiosa. 
Explanted group I valves. Fibrous sheathing was 
evident in the leaflets and chordae tendineae of all 
valves (Fig. 4, A) and involved the inflow surfaces to 
a greater extent than the outflow surface. The 
fibrous sheaths were partially lined by endothelial 
cells of host origin (Fig. 4, B). The main cellular 
components of the fibrous sheaths were fibroblasts 
and myofibroblasts, as well as a few macrophages 
and lymphocytes. The collagen fibers in the leaflets 
were more eosinophilic than those in the fibrous 
sheaths (because of the preimplantation treatment 
of the valves with glutaraldehyde), The fibroblasts 
and myofibroblasts in the leaflets (Fig. 4, C) were 
considered to be of donor origin. However, a few 
fibroblasts and macrophages of host origin appeared 
to have infiltrated from the fibrous sheaths into the 
leaflet tissue (Fig. 4, D). All leaflets showed calcifi- 
cation, mainly in the fibrosa at the base of the valve 
(Fig. 4, A). Calcific deposits were diffusely present 
on the collagen fibers. These deposits were homo- 
geneous in their central portions and granular in 
their peripheral portions. 
Thin fibrous sheaths were found on the chordae 
tendineae, mainly in areas adjacent o the papillary 
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Fig. 4. Histologic features of explanted group I allografts. A, Fibrous sheathing is evident on the leaflet 
(arrowheads). Note the extensive calcific'deposits n the fibrosa (*). (Hematoxylin-eosin tain, • B, 
Endothelial cells, presumed to be of host origin, cover the surface of the fibrous sheath. Note the boundary 
(arrowheads) between fibrous sheath and donor tissue. (Hematoxylin-eosin tain, x200.) C, Mesenchymal 
cells of donor origin in the leaflet have weakly stained nuclei and pale cytoplasm (arrowheads). This region 
of the leaflet is not covered by fibrous sheath, and theendothelial cells of donor origin have been lost from 
the surface. (Hematoxylin-eosin tain, • D, A few fibroblasts and macrophages of host origin have 
infiltrated into the leaflet issue (*) beneath the fibrous sheath (FS). (Hematoxylin-eosin tain, • 
muscles. Calcium deposits were found in the central 
fibrous cores of the chordae in each of the four 
valves. The organization of the !calcific deposits in 
the chordae was similar to that observed in the 
leaflets..The collagen bundles in heavily calcified 
chordae were markedly disrupted. 
Explanted group II valves. Fibrous sheathing was 
evident in the leaflets and chordae tendineae of all 
eight valves. At least the proximal one third of both 
surfaces of the leaflets was covered by fibrous 
sheathing (Fig. 5, A). Both the extent and the 
thickness of the fibrous sheathing were greater on 
the outflow surfaces than on the inflow surfaces. In
five valves, fibrous sheathing that originated from 
ventricular endocardium lined the chordae tendi- 
neae and extended into the areas of the free edge 
and distal one third of the leaflets (Fig. 5, B). All 
fibrous sheaths were lined by endothelial cells; how- 
ever, the remaining portions of the leaflets were 
completely denuded. In contrast o the findings in 
group I valves, the staining characteristics of the 
collagenous fibers were similar in the fibrous sheaths 
and in the leaflets. Calcific deposits were not found 
in any of the fibrous sheaths. 
The spongiosa in the basal third of the leaflet wa~ 
penetrated by fibroblasts and myofibroblasts thal 
appeared to have originated from the site of attach- 
ment of the allograft o the host tissue. The middk 
third of the leaflet was largely ace!lular, and the 
distal third was infiltrated by mononuclear cells anc 
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Fig. 5. Hist01ogic features of explanted group II allografts. A, Leaflet surface is covered by thick fibrous 
sheath (arrowheads) Compare with Fig. 4, A. Note amorphous appearance of donor tissue (*). 
(Hematoxylin-eosin tain, x30.) B, The distal third of the leaflet is covered by thin fibrous sheath 
(arrowheads), which has extended from the chordae tendineae. Note infiltration of inflammatory cells of 
host origin. (Hematoxylin-eosin tain, • C, Area of severe infiltration of inflammatory cells, mostly 
macrophages (some of which form aggregates). Note interstitial edema nd layer of fibrin overlying the 
leaflet surface. (Hematoxylin-eosin tain, x 100.) D, Thick fibrous sheathing (arrowheads) covers a chorda 
tendinea. (Hematoxylin-eosin tain, X70.) E, An aggregate of macrophages is found at the boundary 
between fibrous heath (FS) and donor tissue (*). (Hematoxylin-eosin tain, x330.) F, Collagen bundles in 
area infiltrated by macrophages are loosely arranged and frayed. (Hematoxylin-eosin tain, x300.) 
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fibroblasts (Fig. 5, B and C). This infiltration was 
associated with edema, particularly at the free edge 
of the leaflets. Very few cells of donor origin could 
still be recognized in the leaflets of this group of 
valves. The extracellular components of the valves 
showed a homogeneous appearance. The elastic 
fibers were not altered. Calcific deposits were found 
in two of the valves, including one with calcified 
cartilage and bone formation. The calcific deposits 
showed a fine granular appearance and involved 
connective tissue and fibroblasts. 
Fibrous sheaths lined by endothelial cells covered 
most of the chordae tendineae (Fig. 5, D). Fibro- 
blasts, lymphocytes, macrophages, and plasma cells 
were found in these fibrous sheaths and in subjacent 
areas of the chordae (Fig. 5, E). The collagen 
bundles in the fibrous cores were pale and frayed, 
particularly in areas of cellular infiltration (Fig. 5, 
F). Calcific deposits were found in the fibrous cores 
of the chordae in three valves. 
Electron microscopic observations 
Unimplanted, untreated valves. Most of the inter- 
stitial connective tissue cells were myofibroblasts, 
which had prominent rough endoplasmic reticulum, 
Golgi apparatus, relatively large bundles of actinlike 
filaments, and discontinuous, poorly developed 
basement membranes. Some of the cytoplasmic 
processes of adjacent myofibroblasts were in con- 
tact, thus providing intercellular connections. Colla- 
gen fibrils formed thin bundles in the atrialis and 
the ventricularis. In the spongiosa these bundles 
were small and scattered. The fibrosa was charac- 
terized by thick bundles of collagen fibrils. Elastic 
fibers were composed of amorphous components 
(central elastin cores, which appeared lucent in 
sections stained with uranyl acetate and lead 
citrate and electron-dense in sections tained by 
the Kajikawa method 26) and peripherally located, 
longitudinally aligned microfibrils. Elastic fibers 
were most numerous in the atrialis but were also 
frequent in the ventricularis. Small elastic fibers 
were scattered in the spongiosa. At the free edge 
of the leaflet, elastic fibers were small and irreg- 
ularly oriented. Proteoglycan granules were star- 
shaped and were most numerous in the spongiosa. 
These granules were also found diffusely at' the 
free edge of the leaflet. 
Myofibroblasts were the main cellular compo- 
nents of the chordae. The outer zones of the chor- 
dae contained elastic fibers and small amounts of 
proteoglycan granules and collagen fibrils. The inner 
cores consisted of thick bundles of collagen fibrils, 
among which myofibroblasts and a few small elastic 
fibers were scattered. 
Unimplanted group I valves. The surfaces were 
partially denuded of endothelial cells. Some of the 
myofibroblasts showed swelling of the rough endo- 
plasmic reticulum and mitochondria nd margin- 
ation of nuclear chromatin; others howed amaged 
plasma membranes. The structure of the collagen 
fibrils and the elastic fbers was normal. Proteogly- 
can granules were markedly reduced in number. 
Some of the remaining ranules were smaller than 
normai and lacked elongated projections. A mild to 
moderate degree of interstitial edema was present. 
Unimplanted group H valves. Many endothelial 
cells were lost and remaining cells showed pyknotic 
nuclei and lytic changes in their cytoplasm. Myofi- 
broblasts howed similar changes. Collagen bundles 
were separated and loosely arranged, but the peri- 
odicity of the collagen fibrils was still visible. Sparse 
proteoglycan granules were present in the intersti- 
tium. The microfibrils of the elastic fibers sometimes 
had lost their parallel arrangement. Interstitial 
edema was diffusely present. Celt degeneration was 
more severe in this group than in group I valves. 
Explanted group I valves. Endothelial cells of do- 
nor origin were lost from the valvular surfaces and 
the  endothelial cells of host origin covered the 
fibrous sheaths (Fig. 6, A). The fibroblasts and 
myofibroblasts in the fibrous sheaths howed paral- 
lel arrangements, and cytoplasmic processes of ad- 
jacent cells were in contact. The amorphous compo- 
nents of elastic fibers in the fibrous sheaths often 
had a finely granular appearance. Masses of micro- 
fibrils with parallel arrangements also were found 
among the fibroblasts and myofibroblasts in the 
fibrous sheaths. These findings were considered tc 
be indicative of the formation of new elastic fibers. 
Proteoglycan granules also were found in the fibrous 
sheaths, but not in donor tissue. 
The borders between fibrous sheath and donoI 
tissue usually were well demarcated because of the 
presence of typical ayers of elastic fibers near the 
surfaces of the donor tissues (Fig. 6, A). Collage~ 
fibrils in noncalcified areas of the valves sometimes, 
were loosely arranged and frayed or disrupted. 
Some of these fibrils showed a flowerlike appear- 
ance in cross sections ("collagen flowers, ''2v Fig. 6,/3 
and C) and others howed a spiraling appearance ir~
longitudinal sections. Collagen fibrils in the donol 
tissue showed normal periodicity. Amorphous anc 
very finely granular and fibrillar materials were 
present between the collagen fibrils in these valve~' 
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Fig. 6. Ultrastructure of explanted group I allografts. A, Endothelial ceils of host origin cover the fibrous 
sheath. Note the typical ayer of elastic fibers (arrowheads) near the surface of the donor tissue. (Kajikawa 
stain; x5500.) B and C, Some of the collagen fibrils show a flower-like appearance in cross sections. These 
fibrils usually appear dark (B), but in areas of associated calcification (C) they are lucent and are 
surrounded by electron-dense calcific deposits. (B: Kajikawa stain, x36,000; C: uranyl acetate and lead 
citrate stain, x37,000.) D, Amorphous, very finely granular and fibrillar materials are present between the 
collagen fibrils. (Kajikawa stain, X 18,500.) E, Mesenchymal cell in area of diffuse interstitial calcification 
is entirely calcified (*). (Uranyl acetate and lead citrate stain, x4500.) F, G, and H, Calcific deposits 
associated with collagen fibrils and elastic fibers. F, Calcific deposits are confined to the interfibrillary 
spaces o that the collagen fibrils appear lucent. The amorphous components of elastic fibers (*) also have 
deposits composed of needle-shaped crystals. (Uranyl acetate and lead citrate stain, x 23,500.) G, Deposits 
involve the entire thickness of the collagen fibrils. (Uranyl acetate and lead citrate stain, x26,000.) H, 
Microfibrillar components of an elastic fiber have very electron dense, round particles (arrows), which are 
presumed to be caleific deposits, (Uranyl acetate and lead citrate stain, x56,000.) 
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and often were aggregated into masses (Fig. 6, D). 
Some of the mesenchymal cells were relatively well 
preserved. Others were damaged. Calcification in- 
volved both the mesenchymal cells and the extracel- 
lular components of connective tissue. Intramito- 
chondrial, intralysosomal, and intranuclear calcific 
deposits, consisting of needle-shaped, electron- 
dense crystals, were frequently found in these mes- 
enchymal cells. Necrotic cell fragments also were 
calcified. Two patterns of calcification were ob- 
served in the collagen fibrils (Fig. 6, F and G): 
calcification of entire fibrils and calcification local- 
ized to the surfaces of the fibrils. The latter deposits 
were continuous with deposits involving adjacent 
areas of extracellular matrix. The amorphous com- 
ponents of elastic fibers also had calcific deposits 
composed of needle-shaped crystals (Fig. 6, F). 
Microfibrils were not clearly identified in these 
elastic fibers. In peripheral areas of large calcific 
masses, very electron-dense, round particles were 
present in close association with the microfibriilar 
components of the elastic fibers (Fig. 6, G). 
Explanted group II valves. Some of the denuded 
areas of the surfaces were covered by fibrin deposits, 
whereas in others the collagen fibrils were exposed. 
A few of the collagen fibrils in the fibrous sheaths 
showed a spiraling appearance (Fig. 7, A). Elastic 
fibers in the fibrous sheaths were similar to those in 
group I valves. In donor tissues, mesenchymal cells 
showed more severe changes than in group I valves. 
All cells showed disruption of the plasma mem- 
branes and the organelles (Fig. 7, B). Calcific depos- 
its were rarely found in these cells. Newly formed 
elastic fibers, characterized by finely granular ap- 
pearance with numerous microfibrils, were present 
near mesenchymal cells of host origin that had 
infiltrated into leaflet issue (Fig. 7, C). Proteoglycan 
material was found only around these cells. The 
collagen fibrils throughout the donor tissue showed 
a loose arrangement and were more widely sepa- 
rated from each other than was the case in group I
valves (Fig. 7, D). "Collagen flowers" were not 
found. Numerous m!crofibrils, which were morpho- 
logically similar to those associated with elastin, 
were scattered through all layers of donor tissue 
(Fig. 7, E and F). Similar accumulations of such 
fibrils were not found in group I valves. 
Discussion 
The present study demonstrates that the results 
obtained with the sheep mitral valve allograft model 
depend on the type of preimplantation processing of 
the allograft. These results dearly show that the 
glutaraldehyde-treated allografts undergo rapid, se- 
vere calcification resulting in marked stenosis and 
functional failure. These changes also can result in 
mitral regurgitation from fracture of calcified chor- 
dae tendineae. In contrast, the allografts preserved 
by treatment with antibiotics undergo progressive 
disruption of the connective tissue in the chordae 
tendineae and leaflets and infiltration by inflamma- 
tory cells. These alterations lead to progressive 
mitral regurgitation. Thus the findings of the present 
study are in agreement with. those of Maxwell, 
Gavin, and Barratt-Boyes, s' 9 who found that glutar- 
aldehyde-treated porcine aortic valve xenografts im- 
planted in the mitral position in patients calcified 
very frequently but detached from the commissures 
very infrequently, whereas antibiotic-preserved aor-' 
tic valve allografts implanted in the mitral position 
showed much less calcification but had a much 
higher incidence of cuspal damage and detachment. 
Glutaraldehyde-treated valves. This study pro- 
vides the first evaluation of the postimplantation 
changes that develop in glutaraldehyde-treated mi- 
tral valves implanted orthotopically. The calcifica- 
tion observed in the present study is histologically 
and ultrastructurally similar to that previously re- 
ported with glutaraldehyde-fixed porcine aortic and 
bovine parietal pericardial bioprostheses implanted 
in the sheep model. 2~ 21 As described previously, 
this is a model for accelerated calcification of bio- 
logic tissue valves. Gross anatomic examination 
disclosed that in all four group I valves the calcific 
deposits involved the leaflets and the chordae ten- 
dineae, thus resulting in loss of valvular mobility: It 
became obvious that the mechanical forces exerted 
under these conditions on calcified chordae tendi- 
neae were sufficient o cause their fracture. The 
microscopic patterns of calcification observed in 
these valves were similar to those described in 
porcine aortic valves and bovine pericardial valves 
implanted after glutaraldehyde fixation in the sheep 
model20, 21 and in patients. 2s' 29 The results of the 
present study emphasize the importance of calcifi- 
cation of the chordae tendineae in causing valvular 
stenosis and regurgitation in mitral valvular al- 
lografts. However, other changes in connective tis- 
sue components were much less severe in group I 
than in group II valves. 
Three types of ultrastructural terations of colla- 
gen were observed in the present study: (1) "colla- 
gen flowers," (2) spiraling collagen fibrils, and (3) 
wide separation and loss of collagen fibrils. The 
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Fig. 7. Ultrastructure of explanted group II allografts. A, Some of the collagen fibrils in the fibrous sheath 
show a spiraling appearance. (Kajikawa stain, x28,000.) B, Mesenchymal cell of donor origin appears 
nonviable, with disrupted plasma membrane and organelles. (Kajikawa stain, x 11,500.) C, Small, granular 
elastic fibers (presumed to be newly formed) are present (arrows) near mesenchymal cell of host origin that 
has infiltrated the leaflet issue. (Kajikawa stain, x 6500.) D, The collagen fibrils in donor tissue are loosely 
arranged and are widely separated. Note infiltrating plasma cell. (Kajikawa stain, x6000.) E, and F, Small 
fibrils of undetermined nature are present between collagen fibrils in donor tissue. These fibrils are straight 
or curved and measure from 11 to 14 nm in diameter. Some fibrils appear to have hollow centers 
(arrowheads) in cross section, and some show a periodicity of 10 nm (arrow) in longitudinal views. (E: 
Kajikawa stain, x12,000; F: uranyl acetate and lead citrate stain, x99,000.) 
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"collagen flowers" were observed only in group I 
valves and were similar to those described in several 
inheritabledisorders of connective tissue. 27 Such 
fibrils have been thought to result from either 
abnormal synthesis or partial degradation of colla- 
gen and are not specific for any disease ntity. In the 
valves in the present study, such fibrils probably 
occurred as consequences of partial degradation of
glutaraldehyde-crosslinked collagen fibrils. Never- 
theless, we have not observed "collagen flowers" in 
explanted glutaraldehyde-fixed porcine aortic valvu- 
lar bioprostheses or bovine pericardial bioprosthe- 
ses. The spiraling substructure also has been inter- 
preted as indicative of partial unraveling of the 
collagen fibrils. In contrast, the loss of collagen 
fibrils observed in group II valves is clearly indica- 
tive of complete disruption. 
Antibiotic-preserved valves. Chordal rupture and 
cuspal perforations were the main anatomic changes 
leading to failure of antibiotic-preserved mitral 
valve allografts. Damage to the connective tissue 
elements, particularly collagen, led to these alter- 
ations. Fibrous sheathing was present on the chor- 
dae tendineae and on the leaflets; however, the 
extent o which this connective tissue reinforcement 
developed was not adequate to prevent chordal 
rupture and leaflet perforation. It seems likely that 
the connective tissue breakdown in these valves 
resulted from several factors including autolytic 
changes before implantation, inflammatory reac- 
tion, and wear and tear associated with the mechan- 
ical forces related to opening and closure of the 
mitral allograft. 
In explanted group II valves, we found extensive 
accumulations of connective tissue microfibrils that 
were morphologically similar to the microfibrils 
associated with elastic fibers. However, such accu- 
mulations of micro fibrils were not observed in un- 
implanted valves, and their mechanism offormation 
remains unknown. 
We observed a cell-mediated immunologic reac- 
tion, characterized by infiltration of lymphocytes, 
plasma cells, and macr0phages, even in areas cov- 
ered by fibrous heaths. This reaction was associated 
with disruption of the connective tissue components. 
Macrophage-derived collagenases probably played 
an important role in this disruption of the connec- 
tive tissue. A similar reaction has been observed in 
explanted antibiotic-preserved human aortic valve 
allogr~fts. 3~ The fact that such a reaction was min- 
ima ! in glutaraldehyde-treated llografts i in agree- 
ment with the concept hat glutaraldehyde fixation 
produces a marked decrease in the antigenicity of 
transplanted valvular tissues. 3~ This treatment also 
increases the crosslinking and the stability of colla- 
gen, 29 accounting for the paucity of collagen disrup- 
tion in the explanted group I valves. 
The only connective tissue cells and endothelial 
cells that appeared to be viable in explanted group II 
valves were localized in the fibrous heaths and their 
immediate vicinity. The connective tissue cells of 
donor origin present in these valves were disrupted. 
Similar observations have been made in antibiotic- 
preserved human aortic valve allografts. 3~ Thus such 
cells do not maintain a functional role in the turn- 
over and renewal of donor valvular connective tissue 
after implantation of the allograft. It remains to be 
determined whether or not cryopreservation f mi- 
tral valve allografts will result in improved viability 
of donor connective tissue cells and endothelial cells 
for long periods after implantation. However, no 
growth of cells of donor origin was found in tissue 
cultures of cryopreserved aortic valve allografts ex- 
planted 8 to 15 months after implantation i  the 
descending aorta of sheep. 32 In contrast, growth of 
cells of donor origin was found in 43% of similarly 
implanted pulmonic valves. The reason for this 
difference is not known. In human beings, aortic 
valve allografts have lasted for very long periods. 3-13 
Structural changes develop in such allografts, in- 
cluding loss of nuclei of connective tissue cells and a 
homogeneous appearance of the connective tissue. 
Other studies have demonstrated ' severe loss of 
endothelial cells in cryopreserved human 33 and rat 34 
aortic valve allografts. These changes are in many 
ways comparable with those observed in the present 
study. These results suggest that under certain cir- 
cumstances the viability of connective tissue cells 
and endothelial cells of donor origin is not necessary 
for good long-term function of aortic valve al- 
lografts. However, we consider that loss of connec- 
tive tissue cell viability, leading to inability to syn- 
thesize new collagen fibrils to replace those that are 
degraded uring normal tissue turnover, is the ulti- 
mate cause of chordal and cuspal disruption in the 
mitral valve allografts in the present study. 
The antibiotic-preserved mitral valve allografts in 
the sheep model failed more quickly and more 
severely than would have been expected on the basis 
of previous experience with aortic and pulmonary 
valve allografts implanted in human beings 3-13 and 
in sheep. 32 Clinical and experimental studies of 
mitral valve allografts have been reported previ- 
ously. Van Vliet and associates 35 found that fresh 
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mitral valve allografts implanted in dogs maintained 
satisfactory function for up to 1 year and reported 
that these valves were gradually remodeled by fi- 
brous connective tissue of host origin without ap- 
parent functional deterioration. Similar results were 
reported by Bernhard and colleagues. 36However, 
other studies have shown that mitral valve allografts 
implanted in human beings w' 16, 37 and in dogs 38' 39 
either had a low rate of survival or exhibited late 
deterioration with a high incidence of rupture of the 
chordae tendineae. We believe that the arrange- 
ment of the connective tissue components in aortic 
valve leaflets makes them more resistant to damage 
by mechanical forces during valvular opening and 
closing. Specifically, a large majority of the collagen 
fibrils in aortic valves are arranged in fibrous cords 
that are oriented parallel to the edge of the cusp and 
attach at the commissures. This arrangement is
clearly different from that in mitral leaflets and 
chordae tendineae. The role of the chordae tendi- 
neae in mitral valve closure is without functional 
parallel in aortic valve closure. This unique role 
places the mitral chordae at high risk of functional 
deterioration because of the substantial mechanical 
forces to which these structures are subjected uring 
left ventricular systole. The lower pressures in the 
right side of the heart may account for the long-term 
durability of tricuspid valve allografts implanted in 
the tricuspid position in dogs. 4~ 
In conclusion, the present study reports the re- 
sults obtained with two types of orthotopic mitral 
valve allografts in sheep. Glutaraldehyde-fixed al- 
lografts failed because of extensive calcification in- 
volving the chordae and the leaflets, and antibiotic- 
preserved allografts failed because of extensive 
alterations in collagen. The development of fibrous 
sheathing of recipient origin was not sufficient o 
provide adequate structural reinforcement of anti- 
biotic-treated allografts undergoing connective tis- 
sue deterioration. 
We acknowledge the assistance of the veterinary pro- 
fessional and technical staff of the Laboratory of Animal 
Medicine and Surgery, National Heart, Lung, and Blood 
Institute. 
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